For too many of our BIPOC neighbors, the lack of coverage for GLP-1 medications means that effective treatment is out of reach, compounding the health risks and economic costs of untreated obesity driving health inequalities
A legitimate physician evaluates whether a GLP-1 medication is appropriate for you at all, then discusses FDA-approved options and, where compounding is permitted and appropriate, licensed-pharmacy compounded options with honest information about the regulatory and safety differences
Environmental Health Perspectives, 113(12), 1705-1711
In certain casessuch as significant insulin resistance or elevated visceral fata provider may consider treatment on an individual basis
A review of the literature on the effects of low doses of alcohol on driving-related skills
According to the most recent round of Indias largest national health survey, one in four people with diabetes had not been diagnosed